Ligita Jančorienė, MD, PhD, is a Professor in the Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Medical Faculty, Vilnius University and an infectious diseases specialist and head of the Centre of Infectious Diseases of Vilnius University Hospital Santaros klinikos.
She graduated from Vilnius University Medical faculty in 1989 and finished her residency in gastroenterology in 1993. From 1996 she is working in the Vilnius University Hospital and from 1997 in Vilnius University, from Jun 2016 she is a Professor of Vilnius University. During her PhD studies she got clinical training in infectious diseases in Karolinska Institutet, Huddinge University hospital, Stockholm, Sweden (1999-2003). In 2003 she defended her thesis in field of treatment of chronic viral hepatitis C. In 2004 she received license for medical practice in infectious diseases and gastroenterology. She attended the postgraduate courses on Travellers’ Health held in Swiss Tropical Institute in Basel, Swiss; course on Hepatology in Hepatobiliary school, Ljubljana, Slovenia; Zalcburg – Cornell Seminars on Infectious Diseases in Salzburg, Austria and international exchange program on chronic hepatitis C, in the University of Pennsylvania, Philadelphia, USA. During her professional career she also participated in clinical training and preceptorship programs in University hospitals in Sweden, Germany, France, Spain and USA. On 2010 in Boston, US, she passed the Certificate of Knowledge Examination developed by an international panel of travel medicine experts of International Society of Travel Medicine and was granted a "Certificate in Travel Health™" which recognizes individual excellence in knowledge in the field of travel medicine, associated with pre-travel care and consultation.
She was involved in the coordinating committee of the Lithuanian consensus process of management of chronic viral hepatitis C and HIV infection. She is member of the steering group for the development of a National Viral Hepatitis Strategy. She is a member of the Independent expert group (NEG) at the National Immunoprophylaxis Program. Since 2012 is a member of Central European Vaccination Awareness group (CEVAG). Since the beginning of the COVID-19 pandemic, she has participated in the activities of an expert group under the Government of the Republic of Lithuania, and is a member of the Council of Health Experts established by the President of the Republic of Lithuania. From 2020 December 18 by the Prime Minister's Decree became a member of the Advisory board of independent experts group for the consideration and submission of proposals for the COVID-19 disease management.
She has been co-principal and principal investigator in more than 35 clinical trials in treatment and prophylaxis of viral hepatitis B and C, influenza and adult vaccination. From start of COVID-19 pandemic in 2020 she became a principal investigator of 6 and an investigator in 4 biomedical research studies of COVID-19 infection and as executor was involved in project "Evidence-based recommendations for improving laboratory diagnosis and prognosis of COVID-19 infection" funded by Research Council of Lithuania. Currently she is principal investigator of biomedical research of European hospital surveillance, risk factors and vaccine effectiveness I-MOVE-COVID-19 Network - Multidisciplinary European network for research, prevention and control of the COVID-19 pandemic, principal executor in a “Programable virus nucleic acid detection using CRISPR nucleases (PRECISE)” project, that was funded by Research Council of Lithuania and European Corona Vaccine Trial Accelerator Platform (VACCELERATE) Consortium Coordinator for Lithuania.
She is a member of Lithuanian Society of Gastroenterology, a board member of the Lithuanian Society of Infectious Diseases. She is a member of International Society of Travel Medicine (ISTM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
The main clinical practice and research areas of interest - acute and chronic viral hepatitis, influenza, tick born diseases, HIV and COVID infection, travel medicine, adult vaccination.
Ligita Jančorienė is the author of 50 scientific articles form which 28 journals listed in Clarivate Analytics Web of Science database with citation index; author and co-author of 4 medical textbooks and methodological monographs.
